Insulet Corporation (Nasdaq: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Companys OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.
Insulet Corporation to Present at Upcoming Investor Conference Wed, 22 Nov 2017 13:00:00 +0000 Insulet Corporation , the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference in New York City, New York on November 28, 2017, at 12:30pm .
ETFs with exposure to Insulet Corp. : November 13, 2017 Mon, 13 Nov 2017 18:02:24 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Insulet Corp. Here are 5 ETFs with the largest exposure to PODD-US. Comparing the performance and risk of Insulet Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Insulet Announces Pricing of Convertible Senior Notes Due 2024 Wed, 08 Nov 2017 12:15:00 +0000 Insulet Corporation , a leader in tubeless insulin pump technology with its Omnipod® Insulin Management System , has priced a private placement of $350 million principal amount of convertible senior notes due 2024 .
Insulet Corp. :PODD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Tue, 07 Nov 2017 13:13:14 +0000 Categories: Yahoo FinanceGet free summary analysis Insulet Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Insulet Corp. – Tandem Diabetes Care, Inc., DexCom, Inc., Eli Lilly and Company, Abbott Laboratories and Johnson & Johnson (TNDM-US, DXCM-US, LLY-US, ABT-US and JNJ-US) that have also reported ... Read more
(Read more...)
Insulet Corp. breached its 50 day moving average in a Bullish Manner : PODD-US : November 6, 2017 Mon, 06 Nov 2017 12:19:10 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Insulet Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
(Read more...)
Insulet Corporation (Nasdaq: PODD) to Ring The Nasdaq Stock Market Closing Bell Fri, 03 Nov 2017 14:00:00 +0000 What: Insulet Corporation, an innovative medical device company dedicated to making the lives of people with diabetes easier, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, ...
Insulet reports 3Q loss Thu, 02 Nov 2017 20:59:01 +0000 On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 4 cents. The results exceeded Wall Street expectations. The average estimate of 14 analysts surveyed by Zacks Investment ...
Insulet Reports Third Quarter 2017 Financial Results Thu, 02 Nov 2017 20:01:00 +0000 Insulet Corporation , the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System , today announced financial results for the three months ended September 30, 2017.
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 2.10 (median winner: 1.53)
Liquidity: 1.15% (median winner: 1.18%)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.